MONIQUEIA FLINT: Open Payments
NPI 1073062915 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$892 in 28 payments from 11 companies in 2025. Trend: 2023 $542 · 2024 $709 · 2025 $892
Food & beverage: $892
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $162 |
| Xeris Pharmaceuticals, Inc. | 1 | $122 |
| Eisai Inc. | 1 | $120 |
| Novo Nordisk Inc | 5 | $100 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $98 |
| Lilly USA, LLC | 4 | $77 |
| AstraZeneca Pharmaceuticals LP | 4 | $63 |
| Amgen Inc. | 4 | $59 |
| Exact Sciences Corporation | 2 | $45 |
| Abbott Laboratories | 1 | $28 |
Products named: VRAYLAR, RECORLEV, Leqembi, MOUNJARO, AIRSUPRA, Ozempic, Cologuard Collection Kit, OTEZLA.
Industry payments across TN — which companies pay providers there.
